hg_157483.1

Basic information about the TSS

---

TSS ID: hg_157483.1 Species: human Chr: chr16		Start: 56451345 End: 56451356 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000567110.1 BX537360 AK312721 Distance: 0 GeneID: 11051 HGNC/MGI_ID: HGNC:13870 UniProt_ID: B2R6U8

Gene_name: nudix hydrolase 21 Gene_symbol: NUDT21 Gene_synonyms: CFIM25 Gene_source: HGNC:13870

TATA-Box annotation

---

Distance to TSS:	-19
Nearest PromoterID:	NM_007006
Entrez ID:	11051
Nearest Unigene:	Hs.528834
Nearest Refseq:	NM_007006
Nearest Ensembl:	ENSG00000167005
Gene Name:	nudix hydrolase 21
Gene Alias:	CFIM25|CPSF5
Gene Description:	nudix hydrolase 21
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.636816
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUDT21 p2@NUDT21
Sample		p1@NUDT21	p2@NUDT21
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	130.91	17.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	133.13	23.87
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	126.93	20.64
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	130.15	17.05
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	128.23	19.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	116.29	19.96
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	141.84	25.49
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	134.92	23.74
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	133.15	20.09
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	137.95	23.76
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	130.97	22.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	140.26	20.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	95.10	9.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	79.99	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	88.70	9.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	87.52	9.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	88.67	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	74.24	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	82.64	8.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	87.26	7.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	88.74	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	78.03	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	73.94	6.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	78.87	7.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	83.07	8.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	78.18	7.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	90.11	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	99.25	9.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	83.51	10.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	88.49	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	86.46	8.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	86.55	9.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	80.19	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	78.35	8.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	85.64	8.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	76.65	8.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	84.20	8.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	82.61	10.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	96.16	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	79.46	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	85.40	6.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	79.20	9.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	91.53	10.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	93.88	8.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	92.96	9.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	88.41	10.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	84.21	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	96.87	11.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	89.29	9.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	98.27	12.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	108.83	15.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	129.87	17.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	97.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	103.62	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	90.47	10.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	79.70	14.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	74.86	10.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	106.63	10.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	98.28	12.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	79.21	12.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	94.48	8.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	95.33	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	46.18	7.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	76.79	10.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	107.87	15.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	94.78	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	258.62	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	106.77	8.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	113.06	13.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	107.90	11.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	129.49	17.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	129.61	11.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	120.77	10.40
Adipocyte - breast, donor1	11376-118A8	51.32	6.18
Adipocyte - breast, donor2	11327-117E4	41.71	9.14
Adipocyte - omental, donor1	11473-119C6	63.10	6.62
Adipocyte - omental, donor2	11474-119C7	35.13	5.23
Adipocyte - omental, donor3	11475-119C8	46.22	7.37
Adipocyte - perirenal, donor1	11476-119C9	41.47	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	52.78	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	65.03	9.03
Adipocyte - subcutaneous, donor3	11408-118E4	54.04	7.99
Adipocyte differentiation, day04, donor1	13019-139D4	93.87	7.43
Adipocyte differentiation, day04, donor2	13022-139D7	82.36	9.01
Adipocyte differentiation, day04, donor3	13025-139E1	86.14	10.31
Adipocyte differentiation, day04, donor4	13028-139E4	114.04	9.99
Adipocyte differentiation, day08, donor1	13020-139D5	63.70	8.77
Adipocyte differentiation, day08, donor2	13023-139D8	94.57	12.91
Adipocyte differentiation, day08, donor3	13026-139E2	65.58	7.46
Adipocyte differentiation, day08, donor4	13029-139E5	93.48	11.13
Adipocyte differentiation, day12, donor1	13021-139D6	59.06	10.40
Adipocyte differentiation, day12, donor2	13024-139D9	58.52	7.53
Adipocyte differentiation, day12, donor3	13027-139E3	63.81	7.85
Adipocyte differentiation, day12, donor4	13030-139E6	56.02	5.78
Alveolar Epithelial Cells, donor1	11510-119G7	66.52	15.03
Alveolar Epithelial Cells, donor2	11590-120G6	24.02	6.10
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	70.34	8.46
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	47.25	5.34
Anulus Pulposus Cell, donor1	11248-116E6	94.40	11.79
Anulus Pulposus Cell, donor2	11463-119B5	81.06	7.10
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	55.71	6.29
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	59.04	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	70.63	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	57.39	5.68
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	65.76	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.75	6.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	53.28	8.12
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	67.48	5.83
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	51.67	7.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	62.90	6.03
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.25	5.08
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	68.96	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	63.59	7.74
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	74.19	7.69
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	53.58	5.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	56.30	5.10
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	62.28	8.29
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	6.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	60.54	4.64
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	86.45	10.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	59.86	6.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	92.29	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	54.85	6.80
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	66.02	6.83
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	56.93	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	54.15	6.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	52.37	6.20
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.13	6.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	63.81	3.28
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	55.31	6.43
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	55.65	8.56
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	47.38	6.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	56.90	6.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	53.46	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	72.22	9.15
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	57.56	8.66
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	58.45	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	53.94	6.47
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	58.64	6.56
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.42	5.22
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	61.41	7.56
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	51.20	5.59
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	78.76	13.90
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	10.56
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	55.32	6.22
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	76.41	6.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	58.32	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	62.30	4.14
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	12.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	76.27	9.15
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	66.68	6.19
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	62.42	7.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	59.75	7.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.10	7.32
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	73.24	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	53.73	9.42
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	65.14	6.36
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	67.60	10.54
Astrocyte - cerebellum, donor1	11500-119F6	97.88	14.25
Astrocyte - cerebellum, donor2	11580-120F5	60.25	7.70
Astrocyte - cerebellum, donor3	11661-122F5	32.09	4.61
Astrocyte - cerebral cortex, donor1	11235-116D2	144.66	16.73
Astrocyte - cerebral cortex, donor2	11316-117D2	160.16	23.13
Astrocyte - cerebral cortex, donor3	11392-118C6	155.43	20.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	253.11	39.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	255.07	40.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	269.47	40.40
Basophils, donor1	12241-129G9	60.68	4.97
Basophils, donor2	12242-129H1	131.33	14.07
Basophils, donor3	12243-129H2	67.91	6.61
Bronchial Epithelial Cell, donor1	11511-119G8	31.48	5.17
Bronchial Epithelial Cell, donor2	11591-120G7	31.09	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	136.30	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	81.59	15.06
Bronchial Epithelial Cell, donor5	11457-119A8	80.68	11.85
Bronchial Epithelial Cell, donor6	11461-119B3	87.74	12.90
Bronchial Epithelial Cell, donor7	11769-123I5	93.03	17.09
Burkitt's lymphoma cell line:DAUDI	10422-106C8	341.53	33.60
Burkitt's lymphoma cell line:RAJI	10476-106I8	295.32	40.76
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	190.27	22.06
CD133+ stem cells - cord blood derived, pool1	12223-129E9	258.55	51.71
CD14+ Monocytes, donor1	11224-116B9	64.25	7.89
CD14+ Monocytes, donor2	11305-117B9	56.61	7.61
CD14+ Monocytes, donor3	11381-118B4	52.47	5.05
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	89.44	5.94
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	91.36	7.96
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	97.31	10.19
CD14+ monocytes - mock treated, donor1	11863-125A9	51.60	3.76
CD14+ monocytes - mock treated, donor2	11873-125C1	50.69	5.73
CD14+ monocytes - mock treated, donor3	11883-125D2	81.96	5.69
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	41.01	2.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	40.85	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	42.89	3.72
CD14+ monocytes - treated with BCG, donor1	11860-125A6	36.81	2.94
CD14+ monocytes - treated with BCG, donor2	11870-125B7	43.27	4.99
CD14+ monocytes - treated with BCG, donor3	11880-125C8	53.54	7.62
CD14+ monocytes - treated with Candida, donor1	11868-125B5	37.46	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	44.88	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	43.26	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.72	4.16
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	40.31	2.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	61.63	4.16
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	32.26	4.12
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	40.04	4.98
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.65	6.98
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	50.84	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	53.04	4.01
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	74.91	7.15
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	23.51	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	32.41	3.52
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	38.61	3.51
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.31	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	39.40	5.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	54.32	7.76
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	33.58	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.93	3.01
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	41.06	4.64
CD14+CD16+ Monocytes, donor1	11789-124B7	108.33	7.19
CD14+CD16+ Monocytes, donor2	11801-124D1	106.72	9.70
CD14+CD16+ Monocytes, donor3	11912-125G4	89.03	8.01
CD14+CD16- Monocytes, donor1	11788-124B6	105.74	8.88
CD14+CD16- Monocytes, donor2	11799-124C8	97.80	9.43
CD14+CD16- Monocytes, donor3	11910-125G2	116.61	9.14
CD14-CD16+ Monocytes, donor1	11790-124B8	92.88	7.66
CD14-CD16+ Monocytes, donor2	11800-124C9	102.10	7.03
CD14-CD16+ Monocytes, donor3	11911-125G3	106.33	7.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	158.52	18.29
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	116.61	12.88
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	160.52	17.61
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	131.13	12.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	145.81	14.47
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	136.18	9.83
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	126.28	11.77
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	151.60	19.77
CD19+ B Cells, donor1	11544-120B5	136.44	16.44
CD19+ B Cells, donor2	11624-122B4	128.40	11.61
CD19+ B Cells, donor3	11705-123B4	120.65	11.11
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	253.34	52.93
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	224.11	33.56
CD34+ Progenitors, donor1	11545-120B6	146.59	7.03
CD34+ Progenitors, donor2	11625-122B5	144.38	13.48
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	215.31	21.79
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	235.40	21.87
CD4+ T Cells, donor1	11225-116C1	148.89	23.92
CD4+ T Cells, donor2	11306-117C1	157.38	20.21
CD4+ T Cells, donor3	11382-118B5	135.72	16.16
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	167.95	21.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	178.55	25.15
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	205.82	26.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	154.08	21.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	165.05	22.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	240.62	39.55
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	179.34	29.77
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	174.38	25.42
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	161.04	29.98
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	151.97	33.17
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	190.07	29.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	185.67	35.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	199.86	30.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	184.71	31.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	180.76	35.08
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	145.76	21.48
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	169.36	21.44
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	173.94	21.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	221.77	38.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	201.24	35.09
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	210.99	30.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	151.68	12.64
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	146.87	22.10
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	193.94	26.15
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	191.02	25.24
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	193.87	17.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	174.48	23.73
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	203.27	28.25
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	215.21	27.48
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	232.54	29.26
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	199.11	23.28
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	182.82	20.77
CD8+ T Cells, donor1	11226-116C2	131.29	16.37
CD8+ T Cells, donor2	11307-117C2	140.41	16.52
CD8+ T Cells, donor3	11383-118B6	150.48	22.98
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	172.04	41.52
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	156.01	33.07
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	152.94	36.93
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	179.83	41.43
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	175.19	42.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	194.64	42.98
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	181.87	39.76
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	201.88	52.90
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	189.49	43.39
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	214.03	43.47
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	211.20	45.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	184.91	40.76
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	138.33	26.27
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	142.09	24.59
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	175.28	29.09
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	176.84	38.54
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	173.21	34.81
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	148.96	33.70
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	168.28	48.80
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	183.62	46.44
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	165.10	44.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	174.02	41.69
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	171.83	38.62
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	178.51	34.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	153.36	23.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	168.56	18.19
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	140.25	30.05
Cardiac Myocyte, donor1	11525-119I4	71.28	5.48
Cardiac Myocyte, donor2	11605-120I3	122.53	12.35
Cardiac Myocyte, donor3	11686-122I3	83.03	10.52
Chondrocyte - de diff, donor1	11261-116G1	121.33	10.75
Chondrocyte - de diff, donor2	11338-117F6	60.06	6.04
Chondrocyte - de diff, donor3	11410-118E6	62.24	5.69
Chondrocyte - re diff, donor2	11339-117F7	121.75	14.32
Chondrocyte - re diff, donor3	11411-118E7	78.45	6.87
Ciliary Epithelial Cells, donor1	11242-116D9	161.46	19.16
Ciliary Epithelial Cells, donor2	11323-117D9	87.22	12.83
Ciliary Epithelial Cells, donor3	11399-118D4	103.98	12.66
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	109.22	28.24
Corneal Epithelial Cells, donor1	11526-119I5	39.30	5.49
Corneal Epithelial Cells, donor2	11606-120I4	42.09	11.38
Corneal Epithelial Cells, donor3	11687-122I4	44.99	8.18
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	67.69	6.44
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	66.87	6.94
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	53.56	7.13
Dendritic Cells - plasmacytoid, donor1	11228-116C4	79.26	16.06
Dendritic Cells - plasmacytoid, donor2	11309-117C4	84.87	28.73
Dendritic Cells - plasmacytoid, donor3	11385-118B8	106.95	15.49
Endothelial Cells - Aortic, donor0	11207-116A1	96.73	12.17
Endothelial Cells - Aortic, donor1	11263-116G3	90.95	8.21
Endothelial Cells - Aortic, donor2	11340-117F8	92.47	8.20
Endothelial Cells - Aortic, donor3	11412-118E8	91.22	11.80
Endothelial Cells - Artery, donor1	11264-116G4	69.23	7.27
Endothelial Cells - Artery, donor2	11341-117F9	80.47	12.47
Endothelial Cells - Artery, donor3	11413-118E9	102.21	16.13
Endothelial Cells - Lymphatic, donor1	11236-116D3	63.39	6.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	88.85	12.17
Endothelial Cells - Lymphatic, donor3	11393-118C7	103.74	10.43
Endothelial Cells - Microvascular, donor1	11265-116G5	66.86	8.91
Endothelial Cells - Microvascular, donor2	11342-117G1	101.01	14.06
Endothelial Cells - Microvascular, donor3	11414-118F1	42.96	5.53
Endothelial Cells - Thoracic, donor1	11266-116G6	129.64	22.01
Endothelial Cells - Thoracic, donor2	11343-117G2	51.89	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	188.23	29.57
Endothelial Cells - Umbilical vein, donor2	11324-117E1	140.35	22.81
Endothelial Cells - Umbilical vein, donor3	11400-118D5	138.13	25.40
Endothelial Cells - Vein, donor1	11267-116G7	116.03	11.38
Endothelial Cells - Vein, donor2	11344-117G3	110.36	11.18
Endothelial Cells - Vein, donor3	11416-118F3	86.51	13.03
Eosinophils, donor1	12244-129H3	137.22	30.49
Eosinophils, donor2	12245-129H4	125.42	11.55
Eosinophils, donor3	12246-129H5	46.37	21.40
Esophageal Epithelial Cells, donor1	11507-119G4	41.05	2.93
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	62.81	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.35	6.02
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	110.94	11.05
Fibroblast - Aortic Adventitial, donor1	11245-116E3	81.74	12.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.53	5.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	54.42	7.28
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.86	9.75
Fibroblast - Aortic Adventitial, donor3	11401-118D6	84.71	13.95
Fibroblast - Cardiac, donor1	11268-116G8	60.33	8.62
Fibroblast - Cardiac, donor2	11345-117G4	75.79	13.64
Fibroblast - Cardiac, donor3	11417-118F4	37.06	4.73
Fibroblast - Cardiac, donor4	11452-119A3	109.42	12.73
Fibroblast - Cardiac, donor5	11456-119A7	79.57	7.49
Fibroblast - Cardiac, donor6	11460-119B2	108.69	12.58
Fibroblast - Choroid Plexus, donor1	11492-119E7	67.93	8.44
Fibroblast - Choroid Plexus, donor2	11572-120E6	109.15	9.92
Fibroblast - Choroid Plexus, donor3	11653-122E6	124.51	19.04
Fibroblast - Conjunctival, donor1	11531-120A1	49.13	6.23
Fibroblast - Conjunctival, donor3	11692-122I9	111.43	10.69
Fibroblast - Dermal, donor1	11269-116G9	78.65	9.63
Fibroblast - Dermal, donor2	11346-117G5	125.47	23.11
Fibroblast - Dermal, donor3	11418-118F5	71.20	11.73
Fibroblast - Dermal, donor4	11450-119A1	133.85	23.40
Fibroblast - Dermal, donor5	11454-119A5	164.16	27.56
Fibroblast - Dermal, donor6	11458-119A9	172.49	38.49
Fibroblast - Gingival, donor1	11237-116D4	89.33	12.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.30	13.89
Fibroblast - Gingival, donor2	11318-117D4	110.83	19.77
Fibroblast - Gingival, donor3	11394-118C8	83.44	7.73
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	56.03	6.34
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	209.06	39.75
Fibroblast - Gingival, donor6 (control)	11922-125H5	133.74	24.48
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	56.81	11.65
Fibroblast - Gingival, donor7 (control)	11924-125H7	154.29	25.45
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	163.49	24.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	192.40	38.28
Fibroblast - Gingival, donor9 (control)	11927-125I1	88.04	8.07
Fibroblast - Lung, donor1	11270-116H1	96.51	10.87
Fibroblast - Lung, donor2	11347-117G6	137.28	10.45
Fibroblast - Lung, donor3	11419-118F6	94.97	14.14
Fibroblast - Lymphatic, donor1	11506-119G3	84.14	13.33
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	20.15	1.68
Fibroblast - Mammary, donor1	11540-120B1	116.51	15.83
Fibroblast - Mammary, donor2	11620-122A9	67.90	3.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	146.45	23.28
Fibroblast - Periodontal Ligament, donor2	11319-117D5	164.73	32.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	139.22	26.01
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	95.02	8.01
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	73.71	12.42
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	62.63	7.42
Fibroblast - Pulmonary Artery, donor1	11250-116E8	90.75	13.04
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	78.23	14.83
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	40.09	8.02
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	111.49	11.07
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	99.62	13.69
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	81.35	6.93
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	118.84	11.63
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	94.47	10.23
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	122.20	13.49
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	62.76	7.59
Fibroblast - skin normal, donor1	11553-120C5	76.13	9.19
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	89.23	15.04
Fibroblast - skin normal, donor2	11561-120D4	96.24	11.25
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	89.16	11.18
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	108.03	8.62
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	126.16	12.14
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	77.84	6.90
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	93.21	14.59
Fibroblast - skin walker warburg, donor1	11554-120C6	99.02	17.37
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	52.06	7.06
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	116.79	24.40
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	63.45	12.66
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	75.99	15.09
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	64.13	11.50
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	361.34	45.17
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	379.65	45.94
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	342.03	55.63
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	265.28	34.47
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	202.98	32.88
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	287.69	37.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	232.35	30.13
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	203.52	23.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	287.00	40.24
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	265.40	24.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	210.70	25.24
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	273.73	32.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	166.64	18.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	206.12	23.26
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	227.90	29.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	162.24	15.52
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	149.73	17.56
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	190.38	23.17
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	171.67	19.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	159.91	15.10
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	190.35	19.44
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	160.50	14.52
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	149.45	18.49
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	210.68	24.12
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	193.54	18.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	208.01	17.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	139.09	13.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	178.29	19.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	201.93	22.66
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	156.17	15.47
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	136.62	15.33
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	136.91	13.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	134.46	12.56
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	137.63	12.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	143.94	16.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	181.20	18.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	106.79	11.18
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	114.04	14.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	139.88	13.38
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	91.99	9.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	127.78	12.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	123.16	10.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	95.18	11.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	102.42	10.70
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	112.61	13.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	83.68	8.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	109.51	9.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	108.40	9.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	109.66	7.46
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	140.83	13.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	91.28	10.42
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	102.09	10.89
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	98.11	10.17
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	427.38	51.76
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	262.39	27.43
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	371.73	38.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	325.76	40.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	327.76	37.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	426.15	49.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	257.38	29.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	312.93	34.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	389.89	48.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	306.03	38.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	300.42	26.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	280.44	43.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	263.25	33.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	293.35	28.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	283.05	38.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	293.59	19.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	297.40	27.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	293.81	27.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	304.87	29.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	273.18	33.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	217.55	27.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	228.71	28.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	239.41	26.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	247.62	24.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	295.04	31.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	202.59	21.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	225.90	23.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	240.11	25.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	197.64	24.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	272.16	26.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	273.33	39.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	262.35	33.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	234.76	20.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	260.44	24.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	242.49	21.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	230.40	21.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	301.01	35.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	236.88	22.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	244.90	29.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	189.88	15.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	159.97	10.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	146.06	15.53
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	70.76	7.99
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	47.82	5.82
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	112.45	15.74
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	64.07	6.66
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	49.29	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	97.82	22.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	122.38	21.94
Hep-2 cells mock treated, biol_rep3	11900-125F1	106.47	26.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	103.08	22.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	110.89	24.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	116.68	21.31
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	104.11	25.16
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	108.42	23.67
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	115.97	24.03
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	68.83	7.83
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.56	7.36
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	187.71	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	42.33	4.23
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	42.86	3.63
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	113.82	16.43
Hepatocyte, donor1	11523-119I2	72.64	9.68
Hepatocyte, donor2	11603-120I1	92.65	16.16
Hepatocyte, donor3	11684-122I1	75.47	10.43
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	241.49	53.52
Intestinal epithelial cells (polarized), donor1	11246-116E4	205.02	31.11
Iris Pigment Epithelial Cells, donor1	11530-119I9	85.75	11.66
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	124.17	19.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	126.83	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	105.21	20.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	99.95	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	146.26	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	146.19	22.74
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	96.70	26.68
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	145.22	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	97.94	15.88
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	96.45	16.63
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	151.91	41.91
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	85.66	21.42
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	98.98	18.56
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	58.54
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	102.72	15.50
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	122.35	20.93
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	105.93	16.30
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	78.50	18.47
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	91.62	21.70
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	117.26	21.24
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	87.33	19.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	91.61	19.95
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	221.14	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	106.54	26.90
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	118.15	29.22
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	65.72
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	105.85	15.94
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	118.47	32.81
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	221.26	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	92.83	17.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	119.46	23.23
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	85.81	16.05
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	117.65	19.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	132.01	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	96.66	15.30
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	130.57	39.84
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	126.44	25.94
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	102.89	18.31
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	141.74	31.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	146.35	17.42
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	109.88	18.14
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	94.21	12.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	111.13	17.10
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	98.49	19.33
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	117.99	27.23
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	180.05	43.46
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	97.28	11.63
Keratinocyte - epidermal, donor1	11272-116H3	44.15	7.67
Keratinocyte - epidermal, donor2	11349-117G8	56.22	5.86
Keratinocyte - epidermal, donor3	11421-118F8	102.51	16.09
Keratinocyte - oral, donor1	11251-116E9	153.14	24.07
Keratocytes, donor1	11527-119I6	36.45	4.81
Keratocytes, donor2	11607-120I5	56.25	2.34
Keratocytes, donor3	11688-122I5	66.20	7.71
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	10.99
Lens Epithelial Cells, donor1	11529-119I8	102.48	8.63
Lens Epithelial Cells, donor2	11609-120I7	123.06	9.34
Lens Epithelial Cells, donor3	11690-122I7	87.69	6.76
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	76.36	9.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	74.23	9.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	89.10	12.91
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.28	10.22
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	68.71	8.82
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	51.86	6.15
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	77.15	9.85
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	55.87	5.31
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	57.29	7.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	86.23	11.07
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	80.46	7.95
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	49.80	5.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	73.87	11.50
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	76.57	10.02
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	58.78	7.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	77.30	10.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	60.48	6.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	62.22	5.67
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	81.95	10.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	66.19	8.49
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	58.00	5.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	86.81	9.70
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	71.63	11.58
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	66.91	6.96
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	81.91	15.03
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	83.55	11.73
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	56.84	6.47
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	77.04	15.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	68.67	9.22
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.06	6.26
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	85.77	12.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	69.47	9.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	52.16	6.19
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	93.29	12.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	65.48	9.14
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	55.55	5.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	85.56	9.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	89.47	15.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	74.60	10.08
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	72.53	9.60
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	68.35	8.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	50.11	5.91
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	70.90	8.59
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	80.04	9.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	49.44	6.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	72.27	9.16
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	51.99	7.17
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	65.04	6.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	108.77	27.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	144.99	18.41
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	140.28	14.84
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	129.90	22.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	123.08	19.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	147.57	16.81
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	109.75	13.91
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	108.24	21.41
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	105.18	15.61
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	130.58	19.78
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	121.10	18.01
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	128.58	18.70
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	131.46	23.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	126.32	16.58
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	139.26	20.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	152.31	21.39
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	123.80	23.21
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	121.11	18.33
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	142.96	20.25
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	141.88	22.83
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	107.04	22.07
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	130.04	21.02
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	136.00	19.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	118.15	18.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	136.01	21.82
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	108.44	21.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	130.08	18.38
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	133.50	26.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	132.40	21.87
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	124.72	16.50
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	126.81	21.51
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	118.15	23.79
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	124.27	22.14
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	137.88	18.67
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	138.92	26.89
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	112.96	21.55
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	128.36	22.40
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	131.87	14.56
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	127.94	15.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	128.50	19.31
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	108.07	19.20
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	116.86	15.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	133.65	18.79
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	110.43	15.49
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	122.60	21.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	111.64	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	120.58	10.58
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	114.84	18.01
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	174.45	25.44
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	145.64	25.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	145.52	25.16
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	158.08	16.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	144.31	21.62
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	158.62	18.93
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	139.41	27.54
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	139.84	17.37
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	147.81	21.12
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	135.91	19.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	142.19	18.16
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	137.83	21.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	144.25	23.48
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	137.79	20.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	131.91	22.76
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	131.65	19.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	130.25	17.78
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	141.92	22.66
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	144.01	18.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	142.49	20.75
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	120.84	20.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	141.50	27.37
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	130.00	19.35
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	131.20	17.43
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	157.79	27.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	148.27	22.41
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	137.30	18.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	170.47	28.29
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	131.66	19.29
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	137.70	16.64
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	122.15	28.97
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	125.26	22.55
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	148.68	16.26
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	135.82	21.41
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	150.77	26.73
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	116.78	21.82
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	123.90	20.19
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	137.81	17.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	133.92	16.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	110.43	19.17
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	123.11	22.98
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	131.41	16.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	112.04	17.68
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	132.62	18.57
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	149.66	18.71
Macrophage - monocyte derived, donor1	11232-116C8	60.17	7.29
Macrophage - monocyte derived, donor2	11313-117C8	56.70	10.64
Macrophage - monocyte derived, donor3	11389-118C3	71.44	8.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	9.56
Mallassez-derived cells, donor2	11929-125I3	59.26	12.04
Mallassez-derived cells, donor3	11930-125I4	81.59	16.96
Mammary Epithelial Cell, donor1	11273-116H4	113.39	19.53
Mammary Epithelial Cell, donor2	11350-117G9	125.38	23.16
Mammary Epithelial Cell, donor3	11422-118F9	87.80	13.22
Mast cell - stimulated, donor1	11487-119E2	286.09	36.61
Mast cell, donor1	11563-120D6	219.42	14.71
Mast cell, donor2	11565-120D8	99.26	8.32
Mast cell, donor3	11566-120D9	108.96	12.61
Mast cell, donor4	11567-120E1	92.90	11.17
Mast cell, expanded and stimulated, donor5	11940-126A5	130.96	11.42
Mast cell, expanded and stimulated, donor8	11942-126A7	162.85	20.43
Mast cell, expanded, donor5	11939-126A4	166.81	17.78
Mast cell, expanded, donor8	11941-126A6	183.77	16.90
Melanocyte - dark, donor1	11502-119F8	140.69	15.32
Melanocyte - dark, donor2	11582-120F7	111.09	14.88
Melanocyte - dark, donor3	11663-122F7	118.80	16.59
Melanocyte - light, donor1	11274-116H5	47.48	6.58
Melanocyte - light, donor2	11351-117H1	59.37	7.51
Melanocyte - light, donor3	11423-118G1	46.83	9.54
Melanocyte, donor1 (MC+1)	12641-134G4	77.68	16.45
Melanocyte, donor2 (MC+2)	12739-135I3	116.99	18.56
Melanocyte, donor3 (MC+3)	12837-137B2	94.82	11.52
Meningeal Cells, donor1	11493-119E8	122.94	20.35
Meningeal Cells, donor2	11573-120E7	89.79	11.00
Meningeal Cells, donor3	11654-122E7	190.39	28.53
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	110.64	13.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	73.66	8.45
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26.28	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	37.94	17.01
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	121.28	25.12
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	67.34	7.84
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	65.85	9.55
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	80.87	14.06
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	76.71	10.96
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	71.61	13.71
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	94.46	9.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.05	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	88.55	8.95
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	38.87	3.26
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	75.57	11.53
Mesenchymal stem cells - adipose, donor0	11217-116B2	131.14	21.62
Mesenchymal stem cells - hepatic, donor0	11218-116B3	68.49	3.75
Mesenchymal stem cells - umbilical, donor0	11214-116A8	131.35	32.66
Mesothelial Cells, donor1	11247-116E5	40.31	5.83
Mesothelial Cells, donor2	12156-128G5	34.03	5.00
Mesothelial Cells, donor3	11402-118D7	40.11	5.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	9.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	75.36	12.31
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	73.61	13.84
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	13.83
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	62.61	6.20
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.75	8.71
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	68.82	8.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	66.56	13.50
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	57.51	7.52
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	68.50	11.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	45.13	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	56.23	11.02
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	31.58	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	46.90	5.31
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	8.29
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	43.22	6.86
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	6.71
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	51.18	6.52
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	42.30	8.79
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	20.46	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.45	4.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	48.38	9.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.49	6.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	39.69	4.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.68	8.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.23	4.60
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	33.46	7.10
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.54	4.89
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	49.41	8.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	36.04	6.25
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	42.42	9.61
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	41.05	6.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	50.80	8.32
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	12.14
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.18	5.76
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	56.28	7.69
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	32.01	6.26
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.89	11.62
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.39	9.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.89	2.49
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	51.90	7.01
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	61.10	8.31
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.89	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	39.22	7.84
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	53.01	7.10
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	38.79	8.31
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.93	11.38
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.27	4.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.54	6.48
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	47.62	7.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	26.68	7.62
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	43.77	3.20
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	76.03	13.17
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	28.39	3.25
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	57.33	6.37
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.61	8.85
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	39.06	6.07
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	46.03	6.25
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	55.80	11.55
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	49.98	8.82
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	67.18	9.51
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	50.69	6.59
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	75.04	7.44
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	94.17	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	74.85	8.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	90.69	7.23
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	93.62	9.47
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	88.56	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	122.93	7.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	106.27	10.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	65.79	5.59
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	60.06	4.64
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	70.73	5.16
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	87.58	5.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	74.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	70.55	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	85.01	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	85.84	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	63.25	7.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	40.69	5.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	44.54	5.67
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	58.91	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	60.54	7.54
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	62.71	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	136.84	22.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	93.07	19.62
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	145.27	29.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	102.13	14.36
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	94.51	10.20
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	95.56	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	122.21	14.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	135.98	21.62
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	146.19	14.59
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	115.42	10.72
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	107.21	11.42
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	77.14	11.10
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	108.81	13.83
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	106.31	9.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	96.60	8.57
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	99.19	9.55
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	101.45	9.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	75.81	14.77
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	94.32	11.87
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	86.07	8.47
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	101.97	11.95
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	99.30	10.11
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	134.96	11.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	54.84	14.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	93.55	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	97.13	9.36
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	94.84	6.77
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	80.22	13.53
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	132.64	12.02
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	154.61	16.99
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	84.76	9.02
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	90.87	8.73
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	118.87	18.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	110.48	13.24
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	99.72	12.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	109.82	11.77
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	72.82	5.88
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	104.07	10.58
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	115.02	9.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	173.12	22.82
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	84.22	11.87
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	98.29	9.38
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	80.23	7.07
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	91.48	7.45
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	153.03	18.90
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	95.05	11.65
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	118.64	12.71
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	113.92	15.03
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	57.82	13.60
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	15.17
Myoblast, donor1	11241-116D8	53.79	9.94
Myoblast, donor2	11322-117D8	79.02	9.21
Myoblast, donor3	11398-118D3	75.84	11.44
NK T cell leukemia cell line:KHYG-1	10777-110G3	233.93	28.46
Natural Killer Cells, donor1	11230-116C6	133.46	13.22
Natural Killer Cells, donor2	11311-117C6	132.08	14.78
Natural Killer Cells, donor3	11387-118C1	119.82	13.44
Neural stem cells, donor1	11275-116H6	266.76	30.49
Neural stem cells, donor2	11352-117H2	362.02	38.51
Neurons, donor1	11494-119E9	224.17	15.93
Neurons, donor2	11574-120E8	180.09	18.49
Neurons, donor3	11655-122E8	229.38	20.55
Neutrophils, donor1	11233-116C9	63.10	13.92
Neutrophils, donor2	11314-117C9	66.67	8.70
Neutrophils, donor3	11390-118C4	79.41	8.55
Nucleus Pulposus Cell, donor1	11252-116F1	110.78	8.67
Nucleus Pulposus Cell, donor2	11409-118E5	116.57	7.16
Nucleus Pulposus Cell, donor3	11462-119B4	64.98	8.82
Olfactory epithelial cells, donor1	11933-125I7	83.00	8.95
Olfactory epithelial cells, donor2	11934-125I8	84.68	10.86
Olfactory epithelial cells, donor3	11935-125I9	74.35	7.95
Olfactory epithelial cells, donor4	11936-126A1	95.94	9.35
Oligodendrocyte - precursors, donor1	11496-119F2	86.66	15.65
Osteoblast - differentiated, donor1	11276-116H7	68.70	6.17
Osteoblast - differentiated, donor2	11353-117H3	37.72	1.14
Osteoblast - differentiated, donor3	11425-118G3	52.14	4.34
Osteoblast, donor1	11277-116H8	73.88	10.55
Osteoblast, donor2	11354-117H4	146.08	17.56
Osteoblast, donor3	11426-118G4	132.94	13.86
Pancreatic stromal cells, donor1	11249-116E7	98.47	16.26
Pericytes, donor1	11491-119E6	20.92	2.56
Pericytes, donor2	11571-120E5	25.35	2.94
Pericytes, donor3	11652-122E5	53.51	8.34
Perineurial Cells, donor1	11499-119F5	106.13	12.09
Perineurial Cells, donor2	11579-120F4	129.37	16.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	112.52	14.98
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	76.15	8.33
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	101.98	9.19
Placental Epithelial Cells, donor1	11278-116H9	38.03	6.70
Placental Epithelial Cells, donor2	11355-117H5	51.01	8.87
Placental Epithelial Cells, donor3	11427-118G5	42.01	2.75
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	41.77	5.70
Preadipocyte - breast, donor1	11467-119B9	51.40	5.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.69	5.87
Preadipocyte - breast, donor2	11328-117E5	46.16	4.95
Preadipocyte - omental, donor1	11468-119C1	53.07	6.07
Preadipocyte - omental, donor2	11329-117E6	64.16	11.35
Preadipocyte - omental, donor3	11403-118D8	45.27	6.45
Preadipocyte - perirenal, donor1	11469-119C2	28.54	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	74.63	13.21
Preadipocyte - subcutaneous, donor2	11356-117H6	156.18	27.27
Preadipocyte - subcutaneous, donor3	11428-118G6	101.32	11.75
Preadipocyte - visceral, donor1	11280-116I2	139.35	23.94
Preadipocyte - visceral, donor2	11357-117H7	113.20	17.03
Preadipocyte - visceral, donor3	11429-118G7	100.21	17.35
Prostate Epithelial Cells (polarized), donor1	11253-116F2	213.91	32.73
Prostate Epithelial Cells, donor2	11331-117E8	40.49	6.23
Prostate Epithelial Cells, donor3	11404-118D9	65.59	12.55
Prostate Stromal Cells, donor1	11254-116F3	94.54	21.41
Prostate Stromal Cells, donor2	11332-117E9	118.70	17.21
Prostate Stromal Cells, donor3	11405-118E1	72.99	9.38
Renal Cortical Epithelial Cells, donor1	11516-119H4	63.14	9.12
Renal Cortical Epithelial Cells, donor2	11596-120H3	92.46	16.01
Renal Epithelial Cells, donor1	11517-119H5	47.68	11.16
Renal Epithelial Cells, donor2	11597-120H4	49.79	9.25
Renal Epithelial Cells, donor3	11678-122H4	128.20	22.13
Renal Glomerular Endothelial Cells, donor1	11514-119H2	52.43	6.81
Renal Glomerular Endothelial Cells, donor2	11594-120H1	77.49	11.72
Renal Glomerular Endothelial Cells, donor3	11675-122H1	169.17	27.97
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	4.66
Renal Mesangial Cells, donor1	11518-119H6	43.14	7.04
Renal Mesangial Cells, donor2	11598-120H5	48.90	5.02
Renal Mesangial Cells, donor3	11679-122H5	23.30	3.33
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	114.62	16.64
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	58.19	10.96
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	63.25	11.57
Retinal Pigment Epithelial Cells, donor0	11215-116A9	97.23	19.19
Retinal Pigment Epithelial Cells, donor1	11528-119I7	53.72	5.40
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	100.11	10.29
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	83.79	11.63
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	216.20	25.91
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	211.89	34.12
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	168.22	27.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	159.54	29.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	128.50	24.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	156.04	29.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	150.34	24.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	126.45	24.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	155.78	27.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	166.48	21.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	124.20	19.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	153.39	28.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	152.49	24.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	116.97	20.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	125.68	26.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	197.87	28.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	120.83	20.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	197.49	32.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	168.14	25.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	113.01	24.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	132.72	20.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	153.25	26.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	129.50	24.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	144.75	26.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	178.32	26.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	109.51	23.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	130.16	22.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	176.20	30.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	124.41	22.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	144.75	22.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	177.70	26.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	123.88	27.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	148.93	29.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	185.05	23.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	141.00	26.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	151.15	25.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	188.44	25.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	138.68	25.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	148.90	25.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	192.42	25.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	117.77	25.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	144.74	27.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	144.21	21.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	109.29	19.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	162.64	17.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	129.77	16.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	151.97	17.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	139.02	16.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	155.06	23.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	213.53	30.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	142.98	18.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	178.13	24.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	124.40	20.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	174.33	29.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	145.47	19.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	154.32	22.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	228.37	34.86
Schwann Cells, donor1	11498-119F4	51.91	9.03
Schwann Cells, donor2	11578-120F3	122.49	34.02
Schwann Cells, donor3	11659-122F3	91.14	11.83
Sebocyte, donor1	11220-116B5	62.99	13.15
Sebocyte, donor2	11301-117B5	50.55	6.89
Sebocyte, donor3	11378-118B1	50.29	5.15
Sertoli Cells, donor1	11255-116F4	54.67	9.94
Sertoli Cells, donor2	11333-117F1	50.84	5.65
Skeletal Muscle Cells, donor1	11281-116I3	83.58	9.33
Skeletal Muscle Cells, donor2	11358-117H8	45.54	5.06
Skeletal Muscle Cells, donor3	11430-118G8	119.55	20.90
Skeletal Muscle Cells, donor4	11451-119A2	147.04	26.86
Skeletal Muscle Cells, donor5	11455-119A6	146.56	26.31
Skeletal Muscle Cells, donor6	11459-119B1	160.21	33.55
Skeletal Muscle Satellite Cells, donor1	11240-116D7	157.89	19.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	135.41	15.12
Skeletal Muscle Satellite Cells, donor3	11397-118D2	161.71	25.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	92.00	8.85
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	67.31	13.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	69.63	9.22
Skin - palm, donor1	10286-104F7	131.62	16.12
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	59.10	11.96
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	118.59	33.53
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	92.44	16.75
Small Airway Epithelial Cells, donor1	11256-116F5	63.94	10.01
Small Airway Epithelial Cells, donor2	11334-117F2	55.84	7.31
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	98.75	14.17
Small Airway Epithelial Cells, donor3	11406-118E2	53.36	8.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	91.65	13.58
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.68	6.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	77.59	9.99
Smooth Muscle Cells - Aortic, donor1	11283-116I5	41.77	6.85
Smooth Muscle Cells - Aortic, donor2	11360-117I1	48.43	9.06
Smooth Muscle Cells - Aortic, donor3	11432-118H1	94.25	12.36
Smooth Muscle Cells - Bladder, donor1	11519-119H7	114.09	11.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	57.36	9.45
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	73.81	7.54
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	81.17	10.50
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	80.75	10.09
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	77.97	14.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	56.23	7.83
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.82	4.88
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	92.85	7.31
Smooth Muscle Cells - Carotid, donor1	11285-116I7	70.47	7.32
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	71.53	9.54
Smooth Muscle Cells - Colonic, donor1	11239-116D6	85.83	10.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	82.87	13.78
Smooth Muscle Cells - Colonic, donor3	11396-118D1	101.39	15.53
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	48.57	6.65
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	49.58	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	70.83	11.36
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	41.31	8.19
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	131.46	10.99
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	54.14	7.45
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.12	12.06
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	69.44	12.68
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	209.82	42.92
Smooth Muscle Cells - Prostate, donor1	11257-116F6	113.85	19.84
Smooth Muscle Cells - Prostate, donor2	11335-117F3	77.01	10.89
Smooth Muscle Cells - Prostate, donor3	11465-119B7	62.40	7.10
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	74.93	11.91
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	66.76	6.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	67.20	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	95.34	15.81
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	46.45	10.60
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	46.70	8.46
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	33.04	6.49
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	135.71	27.66
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	103.71	7.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.72	9.50
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	73.68	9.43
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	89.13	11.66
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	132.48	24.32
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	87.06	9.47
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	39.05	7.14
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	48.44	7.58
Smooth Muscle Cells - Uterine, donor1	11258-116F7	96.78	14.14
Smooth Muscle Cells - Uterine, donor3	11466-119B8	128.15	15.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	79.88	4.66
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	52.89	7.14
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	70.67	10.04
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	79.41	9.70
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	63.03	12.78
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	135.49	19.69
Smooth muscle cells - airway, control, donor1	11966-126D4	70.85	6.60
Smooth muscle cells - airway, control, donor2	11967-126D5	80.26	13.18
Smooth muscle cells - airway, control, donor3	11968-126D6	77.33	6.69
Smooth muscle cells - airway, control, donor4	11969-126D7	84.34	5.50
Synoviocyte, donor1	11291-117A4	68.17	5.55
Synoviocyte, donor2	11368-117I9	59.34	5.20
Synoviocyte, donor3	11440-118H9	44.68	6.93
Trabecular Meshwork Cells, donor1	11532-120A2	89.69	11.43
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	40.52	7.18
Tracheal Epithelial Cells, donor1	11292-117A5	83.94	14.34
Tracheal Epithelial Cells, donor2	11369-118A1	72.67	9.28
Tracheal Epithelial Cells, donor3	11441-118I1	67.00	9.16
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	82.55	12.18
Urethra, donor2	10319-105A4	120.49	8.99
Urothelial Cells, donor1	11520-119H8	31.61	4.78
Urothelial Cells, donor2	11600-120H7	33.65	5.61
Urothelial Cells, donor3	11681-122H7	32.32	5.27
Urothelial cells, donor0	11216-116B1	103.65	15.16
Whole blood (ribopure), donor090309, donation1	12179-129A1	162.83	16.91
Whole blood (ribopure), donor090309, donation2	12180-129A2	175.84	22.87
Whole blood (ribopure), donor090309, donation3	12181-129A3	79.40	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	113.98	11.36
Whole blood (ribopure), donor090325, donation2	12177-128I8	121.43	11.62
Whole blood (ribopure), donor090612, donation1	12182-129A4	139.53	15.62
Whole blood (ribopure), donor090612, donation2	12183-129A5	159.70	13.77
Whole blood (ribopure), donor090612, donation3	12184-129A6	88.55	13.69
Wilms' tumor cell line:G-401	10809-111A8	192.81	21.71
Wilms' tumor cell line:HFWT	10597-108E3	94.16	8.80
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	161.45	37.71
achilles tendon, donor2	10292-104G4	88.86	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	208.81	29.83
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	317.38	47.60
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	141.86	36.68
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	285.72	41.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	285.02	44.13
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	232.21	27.28
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	247.44	33.21
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	204.02	22.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	231.54	26.54
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	222.11	24.07
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	251.34	42.87
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	183.32	27.30
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	231.45	32.53
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	246.99	41.17
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	199.60	30.69
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	179.40	18.59
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	285.00	68.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	193.38	41.75
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	179.64	45.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	188.95	34.27
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	194.73	40.92
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	209.60	35.86
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	202.46	48.36
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	170.95	37.16
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	242.95	39.55
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	248.16	16.14
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	118.09	11.25
adenocarcinoma cell line:IM95m	10796-110I4	159.90	24.26
adipose tissue, adult, pool1	10010-101C1	79.58	7.91
adipose, donor1	10184-103D4	216.97	26.97
adipose, donor2	10185-103D5	233.58	32.04
adipose, donor3	10186-103D6	169.09	24.78
adipose, donor4	10187-103D7	175.95	27.74
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	236.26	29.99
adrenal gland, adult, pool1	10081-102A9	109.13	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	107.39	20.94
alveolar cell carcinoma cell line:SW 1573	10708-109H6	165.79	27.15
amniotic membrane cells, donor1	12235-129G3	54.25	4.17
amniotic membrane cells, donor2	12236-129G4	100.42	13.19
amniotic membrane cells, donor3	12237-129G5	61.57	9.43
amygdala - adult, donor10196	10167-103B5	252.57	23.72
amygdala, adult, donor10252	10151-102I7	125.72	14.80
amygdala, newborn, donor10223	10360-105E9	155.90	19.69
anaplastic carcinoma cell line:8305C	10428-106D5	244.09	32.09
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	109.65	22.28
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	326.69	21.04
aorta, adult, pool1	10052-101G7	88.26	10.40
appendix, adult	10189-103D9	172.32	26.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	130.35	24.08
artery, adult	10190-103E1	80.16	12.23
astrocytoma cell line:TM-31	10425-106D2	161.24	19.99
b cell line:RPMI1788	10427-106D4	213.83	29.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	60.21	7.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	99.23	17.86
bile duct carcinoma cell line:TFK-1	10496-107C1	156.67	27.12
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	173.36	20.69
bladder, adult, pool1	10011-101C2	112.33	11.19
blood, adult, pool1	10053-101G8	90.80	22.15
bone marrow stromal cell line:StromaNKtert	10686-109F2	49.67	5.99
bone marrow, adult	10192-103E3	126.87	21.59
brain, adult, donor1	10084-102B3	135.31	10.25
brain, adult, pool1	10012-101C3	167.48	18.26
brain, fetal, pool1	10085-102B4	219.05	21.37
breast carcinoma cell line:MCF7	10482-107A5	137.10	23.13
breast carcinoma cell line:MDA-MB-453	10419-106C5	175.63	27.84
breast, adult, donor1	10080-102A8	99.12	11.36
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	220.54	23.88
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	290.98	64.32
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	233.67	52.95
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	223.69	39.94
carcinoid cell line:NCI-H1770	10703-109H1	358.27	91.68
carcinoid cell line:NCI-H727	10735-110B6	118.35	21.66
carcinoid cell line:SK-PN-DW	10719-109I8	100.46	15.21
carcinosarcoma cell line:JHUCS-1	10642-109A3	290.93	31.41
caudate nucleus - adult, donor10196	10177-103C6	209.54	20.72
caudate nucleus, adult, donor10252	10164-103B2	141.56	19.91
caudate nucleus, adult, donor10258	10379-105H1	158.18	26.74
caudate nucleus, newborn, donor10223	10354-105E3	154.92	34.43
cerebellum - adult, donor10196	10173-103C2	419.51	52.44
cerebellum, adult, donor10252	10166-103B4	199.63	20.71
cerebellum, adult, pool1	10083-102B2	163.50	17.94
cerebellum, newborn, donor10223	10357-105E6	233.31	24.08
cerebral meninges, adult	10188-103D8	158.09	23.70
cerebrospinal fluid, donor2	10294-104G6	48.97	7.31
cervical cancer cell line:D98-AH2	10552-107I3	244.29	25.59
cervical cancer cell line:ME-180	10553-107I4	174.67	24.53
cervix, adult, pool1	10013-101C4	133.86	15.22
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	105.62	12.26
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	1.31
choriocarcinoma cell line:BeWo	10423-106C9	248.05	42.01
choriocarcinoma cell line:SCH	10785-110H2	217.35	34.38
choriocarcinoma cell line:T3M-3	10618-108G6	105.07	19.21
chorionic membrane cells, donor1	12238-129G6	62.68	5.41
chorionic membrane cells, donor2	12239-129G7	81.04	12.33
chorionic membrane cells, donor3	12240-129G8	73.63	7.14
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	214.08	41.40
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	164.82	26.70
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	185.00	18.58
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	247.30	38.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	270.66	42.33
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	237.00	39.09
chronic myelogenous leukemia cell line:K562	10454-106G4	214.66	45.35
chronic myelogenous leukemia cell line:KU812	10409-106B4	206.42	19.81
clear cell carcinoma cell line:JHOC-5	10638-108I8	186.98	44.57
clear cell carcinoma cell line:TEN	10636-108I6	196.41	37.30
colon carcinoma cell line:CACO-2	10513-107D9	339.18	62.42
colon carcinoma cell line:COLO-320	10420-106C6	523.37	75.26
colon, adult, donor1	10082-102B1	117.81	15.47
colon, adult, pool1	10014-101C5	111.63	12.46
colon, fetal, donor1	10070-101I7	168.09	21.01
common myeloid progenitor CMP, donor1	12130-128D6	96.25	9.17
common myeloid progenitor CMP, donor2	12134-128E1	125.18	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	227.34	36.54
cord blood derived cell line:COBL-a 24h infection	10453-106G3	279.37	51.17
cord blood derived cell line:COBL-a untreated	10449-106F8	290.62	54.01
corpus callosum, adult, pool1	10042-101F6	141.08	17.91
cruciate ligament, donor2	10295-104G7	81.86	11.35
diaphragm, fetal, donor1	10069-101I6	122.79	10.43
diencephalon, adult	10193-103E4	137.75	18.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	214.23	43.63
ductal cell carcinoma cell line:KLM-1	10438-106E6	241.31	45.65
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	135.53	48.87
ductus deferens, adult	10196-103E7	93.19	14.95
duodenum, fetal, donor1, tech_rep1	10071-101I8	182.91	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	189.06	12.51
dura mater, adult, donor1	10041-101F5	116.61	16.52
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	172.99	25.09
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	188.00	27.66
embryonic pancreas cell line:1B2C6	10604-108F1	101.12	13.57
embryonic pancreas cell line:1C3D3	10605-108F2	128.65	20.58
embryonic pancreas cell line:1C3IKEI	10606-108F3	98.80	15.44
embryonic pancreas cell line:2C6	10603-108E9	82.75	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	86.48	16.09
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	171.09	20.30
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	72.53	11.42
epidermoid carcinoma cell line:A431	10426-106D3	194.08	27.57
epidermoid carcinoma cell line:Ca Ski	10431-106D8	252.53	38.60
epididymis, adult	10197-103E8	99.00	11.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	109.46	12.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	112.07	21.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	193.56	30.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	218.59	33.07
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	197.17	39.43
esophagus, adult, pool1	10015-101C6	97.15	12.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	206.26	20.54
eye - muscle inferior rectus, donor1	10272-104E2	115.90	4.83
eye - muscle lateral, donor2	10298-104H1	50.50	8.42
eye - muscle medial, donor2	10299-104H2	47.62	4.46
eye - muscle superior, donor2	10297-104G9	103.18	9.17
eye - vitreous humor, donor1	10268-104D7	51.01	5.83
eye, fetal, donor1	10054-101G9	121.78	12.46
fibrosarcoma cell line:HT-1080	10758-110E2	161.82	29.36
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	180.91	46.53
frontal lobe, adult, pool1	10040-101F4	208.01	19.23
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	151.03	28.52
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	164.40	26.15
gall bladder, adult	10198-103E9	91.02	8.93
gamma delta positive T cells, donor1	11937-126A2	171.26	15.57
gamma delta positive T cells, donor2	11938-126A3	143.05	17.18
gastric adenocarcinoma cell line:MKN1	10614-108G2	91.25	11.19
gastric adenocarcinoma cell line:MKN45	10612-108F9	154.15	20.50
gastric cancer cell line:AZ521	10549-107H9	205.11	27.05
gastric cancer cell line:GSS	10560-108A2	273.65	65.90
gastrointestinal carcinoma cell line:ECC12	10615-108G3	118.57	19.65
giant cell carcinoma cell line:LU65	10487-107B1	89.27	19.28
giant cell carcinoma cell line:Lu99B	10433-106E1	116.31	26.31
glassy cell carcinoma cell line:HOKUG	10688-109F4	140.92	22.20
glioblastoma cell line:A172, tech_rep1	10444-106F3	144.40	29.24
glioblastoma cell line:A172, tech_rep2	10444-106F3	144.79	29.07
glioblastoma cell line:T98G	10485-107A8	206.29	25.28
glioma cell line:GI-1	10413-106B8	124.47	14.35
globus pallidus - adult, donor10196	10175-103C4	228.15	32.80
globus pallidus, adult, donor10252	10161-103A8	127.42	16.84
globus pallidus, adult, donor10258	10367-105F7	121.86	15.06
globus pallidus, newborn, donor10223	10364-105F4	139.09	27.18
granulocyte macrophage progenitor, donor1	12131-128D7	95.44	26.92
granulocyte macrophage progenitor, donor2	12135-128E2	142.07	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	177.70	20.91
granulosa cell tumor cell line:KGN	10624-108H3	58.88	8.32
hIPS +CCl2, biol_rep1	14383-156B9	346.17	33.06
hIPS +CCl2, biol_rep2	14384-156C1	354.84	37.95
hIPS +CCl2, biol_rep3	14385-156C2	412.86	29.63
hIPS, biol_rep1	14380-156B6	613.72	35.93
hIPS, biol_rep2	14381-156B7	424.55	45.95
hIPS, biol_rep3	14382-156B8	206.35	25.38
hairy cell leukemia cell line:Mo	10712-109I1	190.51	28.45
heart - mitral valve, adult	10205-103F7	87.00	10.76
heart - pulmonic valve, adult	10206-103F8	87.86	9.15
heart - tricuspid valve, adult	10207-103F9	80.77	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	75.30	10.20
heart, adult, diseased, donor1	10051-101G6	96.66	8.94
heart, adult, pool1	10016-101C7	113.38	15.41
heart, fetal, pool1	10046-101G1	151.56	13.45
hepatic mesenchymal tumor cell line:LI90	10778-110G4	84.84	10.49
hepatoblastoma cell line:HuH-6	10633-108I3	101.08	20.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	283.75	39.89
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	270.06	36.41
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	293.16	40.02
hepatoma cell line:Li-7	10484-107A7	77.18	14.24
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	268.84	35.58
hippocampus - adult, donor10196	10169-103B7	198.73	19.87
hippocampus, adult, donor10252	10153-102I9	134.30	13.88
hippocampus, adult, donor10258	10374-105G5	218.60	23.90
hippocampus, newborn, donor10223	10363-105F3	131.47	10.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	333.25	40.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	274.11	37.50
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	296.04	39.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	234.57	36.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	203.73	29.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	268.38	37.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	202.91	31.82
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	212.20	24.99
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	231.48	41.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	242.95	28.65
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	199.77	27.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	267.30	37.70
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	257.89	30.51
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	269.72	36.36
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	349.10	40.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	249.71	31.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	270.37	30.09
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	257.88	26.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	215.33	36.17
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	246.91	36.83
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	240.25	45.73
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	150.73	15.02
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	153.86	18.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	168.59	17.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	279.15	39.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	289.56	39.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	341.76	43.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	209.49	29.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	203.98	27.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	221.52	28.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	211.50	29.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	227.14	28.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	192.66	22.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	175.12	19.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	292.29	25.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	203.31	25.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	278.22	38.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	313.74	36.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	345.86	43.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	220.96	30.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	686.43	104.10
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	266.08	37.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	227.13	31.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	229.43	32.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	212.81	34.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	232.71	27.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	236.72	26.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	183.73	22.90
immature langerhans cells, donor1	11904-125F5	103.88	11.62
immature langerhans cells, donor2	11905-125F6	55.45	7.13
insula, adult, pool1	10039-101F3	222.48	21.39
keratoacanthoma cell line:HKA-1	10791-110H8	116.40	15.61
kidney, adult, pool1	10017-101C8	117.35	18.22
kidney, fetal, pool1	10045-101F9	129.80	15.63
large cell lung carcinoma cell line:IA-LM	10509-107D5	143.58	21.16
large cell lung carcinoma cell line:NCI-H460	10839-111E2	89.03	10.37
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	122.94	31.93
left atrium, adult, donor1	10079-102A7	100.25	10.90
left ventricle, adult, donor1	10078-102A6	99.61	10.62
leiomyoblastoma cell line:G-402	10721-110A1	161.98	18.88
leiomyoma cell line:10964C	10569-108B2	37.36	7.18
leiomyoma cell line:15242A	10570-108B3	41.30	5.98
leiomyoma cell line:15425	10571-108B4	53.42	9.96
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	46.00	8.36
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	188.89	11.57
liposarcoma cell line:KMLS-1	10782-110G8	56.39	6.25
liposarcoma cell line:SW 872	10726-110A6	173.26	29.36
liver, adult, pool1	10018-101C9	67.58	8.91
liver, fetal, pool1	10086-102B5	68.67	8.47
locus coeruleus - adult, donor10196	10182-103D2	151.80	20.71
locus coeruleus, adult, donor10252	10165-103B3	105.19	15.69
locus coeruleus, adult, donor10258	10375-105G6	145.87	16.36
locus coeruleus, newborn, donor10223	10362-105F2	111.88	19.77
lung adenocarcinoma cell line:A549	10499-107C4	75.01	14.12
lung adenocarcinoma cell line:PC-14	10408-106B3	57.22	20.68
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	158.05	28.34
lung, adult, pool1	10019-101D1	94.86	8.39
lung, fetal, donor1	10068-101I5	240.60	20.55
lung, right lower lobe, adult, donor1	10075-102A3	115.93	9.62
lymph node, adult, donor1	10077-102A5	130.65	15.15
lymphangiectasia cell line:DS-1	10727-110A7	173.81	24.77
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	268.20	37.73
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	214.92	18.69
mature adipocyte, donor1	12231-129F8	69.26	11.99
mature adipocyte, donor2	12232-129F9	67.24	8.92
mature adipocyte, donor3	12233-129G1	60.69	10.43
mature adipocyte, donor4	12234-129G2	80.28	10.27
maxillary sinus tumor cell line:HSQ-89	10414-106B9	189.42	36.69
medial frontal gyrus - adult, donor10196	10170-103B8	249.29	23.69
medial frontal gyrus, adult, donor10252	10150-102I6	145.47	14.90
medial frontal gyrus, adult, donor10258	10368-105F8	203.32	24.78
medial frontal gyrus, newborn, donor10223	10352-105E1	133.06	22.60
medial temporal gyrus - adult, donor10196	10183-103D3	221.91	23.63
medial temporal gyrus, adult, donor10252	10156-103A3	143.89	12.10
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	306.28	26.97
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	574.14	86.12
medial temporal gyrus, newborn, donor10223	10353-105E2	200.64	24.05
medulla oblongata - adult, donor10196	10174-103C3	194.69	21.42
medulla oblongata, adult, donor10252	10155-103A2	109.14	16.56
medulla oblongata, adult, pool1	10038-101F2	121.46	16.16
medulla oblongata, newborn, donor10223	10361-105F1	115.61	15.62
medulloblastoma cell line:D283 Med	10838-111E1	106.50	15.28
medulloblastoma cell line:ONS-76	10759-110E3	156.88	27.63
melanoma cell line:COLO 679	10514-107E1	85.82	9.20
melanoma cell line:G-361	10465-106H6	53.75	8.42
meningioma cell line:HKBMM	10691-109F7	69.29	10.13
merkel cell carcinoma cell line:MKL-1	10843-111E6	351.58	51.11
merkel cell carcinoma cell line:MS-1	10844-111E7	145.42	17.37
mesenchymal precursor cell - adipose, donor1	11747-123G1	98.35	14.58
mesenchymal precursor cell - adipose, donor2	11748-123G2	64.53	7.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	101.04	9.52
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.32	5.62
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	52.38	4.04
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	79.12	13.88
mesenchymal precursor cell - cardiac, donor1	11752-123G6	45.14	7.55
mesenchymal precursor cell - cardiac, donor2	11753-123G7	55.44	5.18
mesenchymal precursor cell - cardiac, donor3	11754-123G8	75.07	9.02
mesenchymal precursor cell - cardiac, donor4	11755-123G9	75.62	14.58
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	69.14	12.38
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.76	10.54
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	81.50	11.35
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	77.85	15.36
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	64.11	8.17
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	61.83	7.91
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.55	6.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.01	7.30
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	117.90	20.98
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	76.51	9.41
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	56.37	7.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	48.60	9.57
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	52.37	11.45
mesenchymal stem cell line:Hu5/E18	10568-108B1	100.62	25.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	77.18	10.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	80.83	7.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	85.59	12.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	85.34	14.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	74.14	9.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	83.26	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	94.31	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	103.80	11.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	95.18	10.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	88.35	11.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	86.05	10.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	87.27	12.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	84.92	10.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	90.06	9.42
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	87.63	11.17
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	123.05	19.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	170.44	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	107.83	14.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	132.40	16.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	139.13	17.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	118.58	10.63
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	104.18	12.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	144.81	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	135.11	10.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	152.55	23.84
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	125.12	16.01
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	125.50	13.40
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	243.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	131.11	13.93
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	132.10	14.49
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	105.31	15.04
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	91.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	96.43	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	81.90	5.30
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	80.24	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	70.74	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	74.81	7.17
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	72.18	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	100.53	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	100.15	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	99.13	5.51
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	74.72	12.37
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	91.96	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	78.24	8.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	95.10	14.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	21.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	98.83	19.01
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	86.78	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	149.13	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	112.84	10.71
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	82.74	9.13
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	61.33	6.81
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	69.27	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	55.71	12.38
mesothelioma cell line:ACC-MESO-1	10493-107B7	86.23	19.14
mesothelioma cell line:ACC-MESO-4	10494-107B8	107.26	29.42
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	99.15	15.82
mesothelioma cell line:Mero-25	10850-111F4	192.68	36.99
mesothelioma cell line:Mero-41	10851-111F5	83.61	18.82
mesothelioma cell line:Mero-48a	10852-111F6	112.49	20.15
mesothelioma cell line:Mero-82	10853-111F7	126.15	16.56
mesothelioma cell line:Mero-83	10854-111F8	95.66	10.89
mesothelioma cell line:Mero-84	10855-111F9	57.63	11.88
mesothelioma cell line:Mero-95	10856-111G1	145.34	23.19
mesothelioma cell line:NCI-H2052	10847-111F1	85.97	41.74
mesothelioma cell line:NCI-H226	10846-111E9	115.29	20.27
mesothelioma cell line:NCI-H2452	10848-111F2	164.84	32.63
mesothelioma cell line:NCI-H28	10845-111E8	109.17	18.83
mesothelioma cell line:No36	10857-111G2	134.72	22.83
mesothelioma cell line:ONE58	10858-111G3	85.08	15.17
migratory langerhans cells, donor1	11901-125F2	80.03	8.83
migratory langerhans cells, donor2	11902-125F3	70.09	7.94
migratory langerhans cells, donor3	11903-125F4	103.92	9.69
mixed mullerian tumor cell line:HTMMT	10689-109F5	123.74	22.85
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	131.19	20.13
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	174.15	27.18
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	154.14	23.03
myelodysplastic syndrome cell line:SKM-1	10772-110F7	311.74	36.59
myeloma cell line:PCM6	10474-106I6	62.07	9.09
myxofibrosarcoma cell line:MFH-ino	10600-108E6	89.28	7.61
myxofibrosarcoma cell line:NMFH-1	10684-109E9	333.44	37.27
nasal epithelial cells, donor1, tech_rep1	12226-129F3	85.13	16.05
nasal epithelial cells, donor1, tech_rep2	12226-129F3	88.18	18.31
nasal epithelial cells, donor2	12227-129F4	84.45	9.94
neuroblastoma cell line:CHP-134	10508-107D4	367.87	33.13
neuroblastoma cell line:NB-1	10539-107G8	331.70	36.29
neuroblastoma cell line:NBsusSR	10607-108F4	105.44	15.39
neuroblastoma cell line:NH-12	10555-107I6	371.40	32.98
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	69.03	4.74
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	126.23	14.57
neuroectodermal tumor cell line:TASK1	10774-110F9	104.66	12.08
neuroepithelioma cell line:SK-N-MC	10728-110A8	52.13	6.36
neurofibroma cell line:Hs 53.T	10729-110A9	88.37	10.38
neutrophil PMN, donor1	12133-128D9	29.75	14.87
neutrophil PMN, donor2	12137-128E4	66.40	26.56
neutrophil PMN, donor3	12141-128E8	113.65	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	436.50	104.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	148.89	36.02
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	69.89	5.77
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	73.05	9.46
nucleus accumbens, adult, pool1	10037-101F1	182.42	23.53
occipital cortex - adult, donor10196	10172-103C1	300.82	24.72
occipital cortex, adult, donor10252	10163-103B1	124.52	16.37
occipital cortex, newborn, donor10223	10355-105E4	166.32	20.74
occipital lobe, adult, donor1	10076-102A4	255.84	25.98
occipital lobe, fetal, donor1	10073-102A1	471.58	48.92
occipital pole, adult, pool1	10036-101E9	138.68	14.35
olfactory region, adult	10195-103E6	165.83	17.77
optic nerve, donor1	10277-104E7	184.10	20.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	151.16	23.12
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	132.30	19.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	96.35	17.10
oral squamous cell carcinoma cell line:SAS	10544-107H4	173.73	23.33
osteoclastoma cell line:Hs 706.T	10704-109H2	59.97	6.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	96.24	11.21
osteosarcoma cell line:HS-Os-1	10558-107I9	131.26	16.96
ovary, adult, pool1	10020-101D2	140.02	18.34
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	87.44	11.37
pancreas, adult, donor1	10049-101G4	109.11	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	177.50	26.28
papillary adenocarcinoma cell line:8505C	10437-106E5	132.88	23.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	131.64	18.88
paracentral gyrus, adult, pool1	10035-101E8	177.19	21.42
parietal cortex, adult, donor10258	10373-105G4	173.23	29.36
parietal lobe - adult, donor10196	10171-103B9	205.03	24.45
parietal lobe, adult, donor10252	10157-103A4	142.80	16.25
parietal lobe, adult, pool1	10034-101E7	166.72	19.03
parietal lobe, fetal, donor1	10072-101I9	512.07	53.34
parietal lobe, newborn, donor10223	10356-105E5	204.88	23.55
parotid gland, adult	10199-103F1	125.18	16.65
penis, adult	10200-103F2	96.14	16.11
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	183.15	23.43
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	154.58	27.83
pineal gland - adult, donor10196	10179-103C8	113.52	9.68
pineal gland, adult, donor10252	10160-103A7	175.89	19.54
pineal gland, adult, donor10258	10377-105G8	136.08	16.30
pituitary gland - adult, donor10196	10180-103C9	197.30	32.38
pituitary gland, adult, donor10252	10162-103A9	254.86	33.88
pituitary gland, adult, donor10258	10378-105G9	194.08	22.98
placenta, adult, pool1	10021-101D3	85.03	11.93
plasma cell leukemia cell line:ARH-77	10840-111E3	198.51	33.64
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	104.12	15.56
pons, adult, pool1	10033-101E6	155.01	20.31
postcentral gyrus, adult, pool1	10032-101E5	175.66	19.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	96.20	16.73
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	46.94
prostate cancer cell line:DU145	10490-107B4	151.20	33.65
prostate cancer cell line:PC-3	10439-106E7	133.77	26.14
prostate, adult, pool1	10022-101D4	102.39	10.70
putamen, adult, donor10196	10176-103C5	174.45	23.37
putamen, adult, donor10252	10152-102I8	129.41	19.61
putamen, adult, donor10258, tech_rep1	10372-105G3	290.69	34.97
putamen, adult, donor10258, tech_rep2	10372-105G3	131.68	23.68
putamen, newborn, donor10223	10365-105F5	150.68	29.99
rectal cancer cell line:TT1TKB	10469-106I1	136.16	9.31
rectum, fetal, donor1	10067-101I4	278.20	25.04
renal cell carcinoma cell line:OS-RC-2	10411-106B6	133.56	22.90
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	88.23	16.57
retina, adult, pool1	10030-101E3	126.04	16.60
retinoblastoma cell line:Y79	10475-106I7	145.23	16.89
rhabdomyosarcoma cell line:KYM-1	10787-110H4	161.19	17.83
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	189.53	34.31
sacrococcigeal teratoma cell line:HTST	10695-109G2	64.42	12.13
salivary acinar cells, donor1	11771-123I7	66.36	8.25
salivary acinar cells, donor2	11772-123I8	64.71	7.30
salivary acinar cells, donor3	11773-123I9	39.06	5.96
salivary gland, adult, pool1	10093-102C3	122.97	13.73
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	152.10	23.19
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	135.89	21.63
seminal vesicle, adult	10201-103F3	143.91	24.87
serous adenocarcinoma cell line:JHOS-2	10639-108I9	143.57	16.03
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	83.04	12.83
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	182.64	36.13
serous cystadenocarcinoma cell line:HTOA	10693-109F9	116.86	13.97
signet ring carcinoma cell line:Kato III	10436-106E4	171.76	26.20
signet ring carcinoma cell line:NUGC-4	10483-107A6	129.54	19.48
skeletal muscle - soleus muscle, donor1	10282-104F3	67.39	14.90
skeletal muscle, adult, pool1	10023-101D5	94.39	13.55
skeletal muscle, fetal, donor1	10066-101I3	125.63	12.06
skin, adult, donor1	10074-102A2	94.99	6.79
skin, fetal, donor1	10065-101I2	183.69	18.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	214.46	49.03
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	186.60	14.81
small cell lung carcinoma cell line:DMS 144	10841-111E4	204.70	44.52
small cell lung carcinoma cell line:LK-2	10541-107H1	243.61	43.84
small cell lung carcinoma cell line:NCI-H82	10842-111E5	214.25	52.28
small cell lung carcinoma cell line:WA-hT	10562-108A4	126.17	20.70
small intestine, adult, pool1	10024-101D6	123.38	16.12
small intestine, fetal, donor1	10064-101I1	194.35	18.67
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	124.63	25.13
smooth muscle, adult, pool1	10048-101G3	92.27	9.82
somatostatinoma cell line:QGP-1	10781-110G7	132.67	19.03
spinal cord - adult, donor10196	10181-103D1	137.64	16.75
spinal cord, adult, donor10252	10159-103A6	138.78	13.01
spinal cord, adult, donor10258	10369-105F9	122.45	15.91
spinal cord, fetal, donor1	10056-101H2	178.68	17.69
spinal cord, newborn, donor10223	10359-105E8	112.05	15.61
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	71.09	10.60
spleen, adult, pool1	10025-101D7	104.19	11.56
spleen, fetal, pool1	10044-101F8	89.78	10.89
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	125.04	19.67
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	161.96	23.73
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	98.55	10.48
squamous cell carcinoma cell line:T3M-5	10616-108G4	166.15	21.50
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	285.90	33.43
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	199.52	47.87
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	214.92	48.23
stomach, fetal, donor1	10062-101H8	158.06	20.29
submaxillary gland, adult	10202-103F4	120.77	21.08
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27
substantia nigra, adult, donor10252	10158-103A5	97.00	11.63
substantia nigra, adult, donor10258	10371-105G2	188.80	33.10
substantia nigra, newborn, donor10223	10358-105E7	139.90	15.54
synovial sarcoma cell line:HS-SY-II	10441-106E9	253.11	39.66
temporal lobe, adult, pool1	10031-101E4	132.58	15.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	302.71	20.66
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	227.24	22.42
tenocyte, donor1	11763-123H8	92.51	9.43
tenocyte, donor2	11765-123I1	64.47	6.87
tenocyte, donor3	11768-123I4	71.17	5.19
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	293.18	33.31
teratocarcinoma cell line:NCR-G1	10798-110I6	212.72	28.52
teratocarcinoma cell line:PA-1	10807-111A6	274.00	27.59
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	175.70	21.07
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	523.77	53.70
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	154.54	15.92
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	243.63	36.80
testis, adult, pool1	10026-101D8	158.27	52.18
testis, adult, pool2	10096-102C6	235.02	101.49
thalamus - adult, donor10196	10168-103B6	189.89	26.50
thalamus, adult, donor10252	10154-103A1	115.18	14.53
thalamus, adult, donor10258, tech_rep1	10370-105G1	374.13	32.33
thalamus, adult, donor10258, tech_rep2	10370-105G1	119.56	14.33
thalamus, newborn, donor10223	10366-105F6	123.12	24.74
throat, adult	10209-103G2	109.61	15.98
throat, fetal, donor1	10061-101H7	138.34	17.98
thymic carcinoma cell line:Ty-82	10803-111A2	366.06	38.95
thymus, adult, pool1	10027-101D9	182.23	45.03
thymus, fetal, pool1	10043-101F7	139.75	30.44
thyroid carcinoma cell line:KHM-5M	10776-110G2	192.93	40.15
thyroid carcinoma cell line:TCO-1	10783-110G9	217.22	40.23
thyroid, adult, pool1	10028-101E1	114.50	12.97
thyroid, fetal, donor1	10060-101H6	144.49	12.66
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	18.48
tongue, adult	10203-103F5	105.36	12.33
tongue, fetal, donor1	10059-101H5	122.96	13.79
tonsil, adult, pool1	10047-101G2	135.94	22.24
trachea, adult, pool1	10029-101E2	84.17	12.27
trachea, fetal, donor1	10058-101H4	133.49	18.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	114.79	18.78
transitional-cell carcinoma cell line:5637	10418-106C4	136.27	22.39
transitional-cell carcinoma cell line:JMSU1	10492-107B6	251.80	50.45
tridermal teratoma cell line:HGRT	10694-109G1	41.86	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	98.45	12.53
umbilical cord, fetal, donor1	10057-101H3	62.60	8.35
uterus, adult, pool1	10100-102D1	153.57	19.79
uterus, fetal, donor1	10055-101H1	174.57	15.36
vagina, adult	10204-103F6	59.45	7.11
vein, adult	10191-103E2	100.17	13.81
xeroderma pigentosum b cell line:XPL 17	10563-108A5	116.16	14.15